HSDL2 Monoclonal antibody, PBS Only

• 

  WB analysis using 68414-1-Ig (same clone as 68414-1-PBS)

  Various lysates were subjected to SDS PAGE followed by western blot with 68414-1-Ig (HSDL2 antibody) at dilution of 1:20000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 68414-1-PBS in a different storage buffer formulation.

• 

  IF Staining of HeLa using 68414-1-Ig (same clone as 68414-1-PBS)

  Immunofluorescent analysis of (4% PFA) fixed HeLa cells using HSDL2 antibody (68414-1-Ig, Clone: 3D11G1 ) at dilution of 1:800 and CoraLite®488-Conjugated Goat Anti-Mouse IgG(H+L), CL594-Phalloidin (red). This data was developed using the same antibody clone with 68414-1-PBS in a different storage buffer formulation.

HSDL2 Monoclonal Antibody for WB, IF/ICC, Indirect ELISA

Cat No. 68414-1-PBS

Clone No.3D11G1

Host / Isotype

Mouse / IgG2b

Reactivity

Human, pig, rabbit

Applications

WB, IF/ICC, Indirect ELISA

Synonyms

C9orf99, FLJ25855, HSDL2, SDR13C1

---

Product Information

68414-1-PBS targets HSDL2 in WB, IF/ICC, Indirect ELISA applications and shows reactivity with Human, pig, rabbit samples.

• Tested Reactivity: Human, pig, rabbit
• Host / Isotype: Mouse / IgG2b
• Class: Monoclonal
• Type: Antibody
• Immunogen: HSDL2 fusion protein Ag8314
• Full Name: hydroxysteroid dehydrogenase like 2
• Calculated Molecular Weight: 45 kDa
• Observed Molecular Weight: 45 kDa
• GenBank Accession Number: BC004331
• Gene Symbol: HSDL2
• Gene ID (NCBI): 84263
• Conjugate: Unconjugated
• Form: Liquid
• Purification Method: Protein A purification
• UNIPROT ID: Q6YN16
• Storage Buffer: PBS Only
• Storage Conditions: Store at -80°C.

Background Information

Human hydroxysteroid dehydrogenase-like 2 (HSDL2) is a characterized SDR gene that not only catalyses the oxidation and reduction of multiple substrates but also regulates different metabolic and signalling pathways. Accumulating evidences suggest that HSDL2 play an important role in cancer progression. HSDL2 has promoting effects on tumor progression in papillary thyroid cancer, bladder cancer, ovarian cancer, and glioma, but has suppressing effects in cholangiocarcinoma . ( PMID: 31372054, PMID: 32211805)